BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 28161264)

  • 1. Ten-years trends in renal replacement therapy for end-stage renal disease in mainland France: Lessons from the French Renal Epidemiology and Information Network (REIN) registry.
    Vigneau C; Kolko A; Stengel B; Jacquelinet C; Landais P; Rieu P; Bayat S; Couchoud C;
    Nephrol Ther; 2017 Jun; 13(4):228-235. PubMed ID: 28161264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The essential of 2012 results from the French Renal Epidemiology and Information Network (REIN) ESRD registry.
    Lassalle M; Ayav C; Frimat L; Jacquelinet C; Couchoud C;
    Nephrol Ther; 2015 Apr; 11(2):78-87. PubMed ID: 25457107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2017 Annual Report Digest of the Renal Epidemiology Information Network (REIN) registry.
    Lassalle M; Monnet E; Ayav C; Hogan J; Moranne O; Couchoud C;
    Transpl Int; 2019 Sep; 32(9):892-902. PubMed ID: 31148236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.
    Kramer A; Stel V; Zoccali C; Heaf J; Ansell D; Grönhagen-Riska C; Leivestad T; Simpson K; Pálsson R; Postorino M; Jager K;
    Nephrol Dial Transplant; 2009 Dec; 24(12):3557-66. PubMed ID: 19820003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.
    Hruskova Z; Pippias M; Stel VS; Abad-Díez JM; Benítez Sánchez M; Caskey FJ; Collart F; De Meester J; Finne P; Heaf JG; Magaz A; Palsson R; Reisæter AV; Salama AD; Segelmark M; Traynor JP; Massy ZA; Jager KJ; Tesar V
    Am J Kidney Dis; 2019 Feb; 73(2):184-193. PubMed ID: 30122544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Access to the waiting list and renal transplantation].
    Hourmant M; de Cornelissen F; Brunet P; Pavaday K; Assogba F; Couchoud C; Jacquelinet C;
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S139-66. PubMed ID: 24119579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999.
    Stengel B; Billon S; Van Dijk PC; Jager KJ; Dekker FW; Simpson K; Briggs JD
    Nephrol Dial Transplant; 2003 Sep; 18(9):1824-33. PubMed ID: 12937231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal Epidemiology and Information Network: 2007 annual report ].
    Couchoud C; Lassalle M; Stengel B; Jacquelinet C
    Nephrol Ther; 2009 Jun; 5 Suppl 1():S3-144. PubMed ID: 19524212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry.
    Pippias M; Jager KJ; Kramer A; Leivestad T; Sánchez MB; Caskey FJ; Collart F; Couchoud C; Dekker FW; Finne P; Fouque D; Heaf JG; Hemmelder MH; Kramar R; De Meester J; Noordzij M; Palsson R; Pascual J; Zurriaga O; Wanner C; Stel VS
    Nephrol Dial Transplant; 2016 May; 31(5):831-41. PubMed ID: 26361801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical practice patterns and socio-economic factors may explain geographical variation of end-stage renal disease incidence.
    Couchoud C; Guihenneuc C; Bayer F; Lemaitre V; Brunet P; Stengel B;
    Nephrol Dial Transplant; 2012 Jun; 27(6):2312-22. PubMed ID: 22121236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France.
    Couchoud C; Stengel B; Landais P; Aldigier JC; de Cornelissen F; Dabot C; Maheut H; Joyeux V; Kessler M; Labeeuw M; Isnard H; Jacquelinet C
    Nephrol Dial Transplant; 2006 Feb; 21(2):411-8. PubMed ID: 16234286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
    McDonald SP; Russ GR; Kerr PG; Collins JF;
    Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal replacement therapy due to type 1 diabetes; time trends during 1995-2010--a Swedish population based register study.
    Toppe C; Möllsten A; Schön S; Jönsson A; Dahlquist G
    J Diabetes Complications; 2014; 28(2):152-5. PubMed ID: 24332762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in adult renal replacement therapy in the UK: 1982-2002.
    Feest TG; Rajamahesh J; Byrne C; Ahmad A; Ansell D; Burden R; Roderick PJ
    QJM; 2005 Jan; 98(1):21-8. PubMed ID: 15625350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of end stage renal disease on renal replacement therapy in Nepal.
    Hada R; Khakurel S; Agrawal RK; Kafle RK; Bajracharya SB; Raut KB
    Kathmandu Univ Med J (KUMJ); 2009; 7(27):301-5. PubMed ID: 20071881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [REIN annual report 2005. Renal Epidemiology and Information Network & Agence de la biomédecine].
    Couchoud C; Stengel B; Jacquelinet C
    Nephrol Ther; 2007 Apr; 3 Suppl 1():S1-82. PubMed ID: 17703614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UK Renal Registry 16th annual report: chapter 1 UK renal replacement therapy incidence in 2012: national and centre-specific analyses.
    Gilg J; Rao A; Fogarty D
    Nephron Clin Pract; 2013; 125(1-4):1-27. PubMed ID: 24662165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal replacement therapy for rare diseases affecting the kidney: an analysis of the ERA-EDTA Registry.
    Wühl E; van Stralen KJ; Wanner C; Ariceta G; Heaf JG; Bjerre AK; Palsson R; Duneau G; Hoitsma AJ; Ravani P; Schaefer F; Jager KJ
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv1-8. PubMed ID: 25165174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huge progression of diabetes prevalence and incidence among dialysed patients in mainland France and overseas French territories. A second national survey six years apart. (UREMIDIAB 2 study).
    Halimi S; Zmirou D; Benhamou PY; Balducci F; Zaoui P; Maghlaoua M; Cordonnier D
    Diabetes Metab; 1999 Dec; 25(6):507-12. PubMed ID: 10633876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.